Pharma

Healthcare

Novartis Will Pay Up to $1.1 Billion for California Gene Therapy Startup

Photo by Andrew Hecht via CC BY 2.0

Novartis is banking on the startup’s promising treatment candidates for neuromuscular diseases, many of which are genetic in nature.

1 min read
Healthcare

Novo Nordisk’s Doing Brilliantly, Just Not Brilliantly Enough

Photo via Novo Nordisk

Novo Nordisk reported earnings, posting some chunky year-over-year growth and far outperforming its only real rival at the moment, Eli Lilly.

1 min read
Healthcare

Pharmapalooza: Earnings Highlight Highs and Lows of Cutthroat Sector

Photo by Veronique D via iStock

It’s just another earnings week in the life of pharmaceutical CEOs, with blockbuster expectations running up against cruel reality.

2 min read
Healthcare

Study Suggests Weight-Loss Drugs Like Ozempic May Help Alcoholism, Opioid Addiction

Photo by Chemist4U via CC BY-SA 2.0

A new study suggests increasingly popular GLP-1 drugs could help cut opioid and alcohol abuse nearly in half.

1 min read
Healthcare

Weight-Loss Drugs Might Not Tank Medicare After All

Photo by Andres Ayrton via Pexels

New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.

2 min read
Healthcare

Biotech That Once Promised ‘Next Gen’ COVID Vaccine Files for Bankruptcy

Photo by SHVETS Production via Pexels

Gritstone Bio announced it is “taking action” to “preserve value and strengthen capital structure” on Thursday.

2 min read
Technology

Obesity Drugmaker Rivus Wants in on the Healthcare IPO Boom

Photo by Diana Polekhina via Unsplash

Obesity drugmaker Rivus is working with banks to complete a US public listing that could happen before the end of the year.

1 min read
Healthcare

Eli Lilly’s Weight-Loss Drug Finally Off FDA Shortage List

Photo by Jetcityimage via iStock

The Food and Drug Administration declared an end to the scarcity of Eli Lilly’s highly in-demand weight-loss and diabetes drugs on Thursday.

1 min read
Healthcare

Moderna Is Still Stuck in Post-COVID Limbo

Photo by Mufid Majnun via Pexels

Moderna walked a tightrope trying to convince shareholders it can both develop a new portfolio of drugs and keep costs down in the process.

2 min read
Healthcare

Pfizer on Opposite Sides of Two Promising Vaccine Trials

Photo by Anastasia Nelen via Unsplash

Data from two promising vaccine trials heralded potential breakthroughs in the treatment of pneumococcal infection and Lyme disease.

1 min read